Microplate enzyme-linked immunosorbent assay for chagas' disease

Area of Science:

• Immunology
• Infectious Diseases
• Parasitology

Background:

• Chagas' disease, also known as American trypanosomiasis, is a significant public health concern in endemic areas.
• Accurate serological diagnostic tools are crucial for identifying infected individuals and controlling disease spread.
• Existing diagnostic methods may have limitations in terms of cost, complexity, or suitability for large-scale screening.

Purpose of the Study:

• To describe and evaluate a microscale Enzyme-Linked Immunosorbent Assay (ELISA) for detecting antibodies against Trypanosoma cruzi.
• To assess the performance of the developed ELISA using plasma samples from a population in Bahia, Brazil.
• To determine the suitability of this assay for large seroepidemiological surveys.

Main Methods:

• Development of a microscale Enzyme-Linked Immunosorbent Assay (ELISA).
• Assessment of the ELISA using plasma samples from individuals in Bahia, Brazil.
• Comparison of ELISA results with those from the immunofluorescent-antibody (IFA) test.

Main Results:

• The microscale ELISA demonstrated high concordance with the IFA test.
• 98% of individuals with positive IFA tests showed positive ELISA results.
• Less than 2% of individuals with negative IFA tests had positive ELISA reactions, indicating high specificity.

Conclusions:

• The developed microscale ELISA is a sensitive and specific assay for measuring antibodies in Chagas' disease.
• The simplicity and accuracy of the test make it a valuable tool for large-scale seroepidemiological surveys.
• This assay has the potential to aid in the surveillance and control of American trypanosomiasis.